Sunjin Beauty Science Decides Material Spin-off; New Entity No IPO for 5 Years

Sunjin Beauty Science decided a material spin-off at its board meeting on May 7, 2026.
Purpose: secure business independence, resolve conflicts of interest, and strengthen expertise.
The newly spun-off entity (clinical trial business) has no plan to apply for a preliminary listing review within 5 years.
No additional restructuring plan within 1 year after the spin-off.
Opposing shareholders can exercise stock purchase rights at a tentative price of KRW 10,677 per share.
The spin-off plan may be changed through shareholder approval, etc.